α- and β-secretase:: profound changes in Alzheimer's disease

被引:154
|
作者
Tyler, SJ
Dawbarn, D
Wilcock, GK
Allen, SJ [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Mol Neurobiol Unit, URCN Care Elderly, Bristol BS2 8HW, Avon, England
[2] Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England
关键词
Alzheimer's disease; alpha-secretase; amyloid; apolipoprotein E; beta-secretase; BACE; choline acetyltransferase; TACE;
D O I
10.1016/S0006-291X(02)02635-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid plaque, a neuropathological hallmark of Alzheimer's disease, is produced by the deposition of beta-amyloid (Abeta) peptide, which is cleaved from Amyloid Precursor Protein (APP) by the enzyme beta-secretase. Only small amounts of Abeta form in normal brain; more typically this is precluded by the processing of APP by alpha-secretase. Here, we describe a decrease in alpha-secretase (81% of normal) and a large increase in beta-secretase activity (185%) in sporadic Alzheimer's disease temporal cortex. Since alpha-secretase is present principally in neurons known to be vulnerable in Alzheimer's disease, and there is known competition between alpha- and beta-secretase for the substrate APP, it is significant that the majority of Alzheimer samples tested here were low in a-secretase. Eighty percent of Alzheimer brains examined had an increase in beta-secretase, a decrease in alpha-secretase, or both; which may account for the means by which the majority of people develop Alzheimer's disease. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [1] β-secretase as a target for the treatment of Alzheimer's disease
    Citron, M
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 373 - 379
  • [2] Gamma secretase activating protein as profound target for alzheimer\'s disease
    Angira, Deekshi
    Thiruvenkatam, Vijay
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2017, 73 : C1187 - C1187
  • [3] Membrane Anchored and Lipid Raft Targeted β-Secretase Inhibitors for Alzheimer's Disease Therapy
    Ben Halima, Saoussen
    Rajendran, Lawrence
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 : 143 - 152
  • [4] Emerging Alzheimer's disease therapies:: inhibition of β-secretase
    Citron, M
    NEUROBIOLOGY OF AGING, 2002, 23 (06) : 1017 - 1022
  • [5] β-Secretase (BACE) as a drug target for alzheimer's disease
    Vassar, R
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (12) : 1589 - 1602
  • [6] Developing ß-secretase inhibitors for treatment of Alzheimer's disease
    Ghosh, Arun K.
    Brindisi, Margherita
    Tang, Jordan
    JOURNAL OF NEUROCHEMISTRY, 2012, 120 : 71 - 83
  • [7] Evaluation of clinical efficacy of α-secretase in the treatment of Alzheimer's disease
    Sun, Yan
    Chen, Hai
    Wu, Chengyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 6076 - 6081
  • [8] The β-secretase, BACE -: A prime drug target for Alzheimer's disease
    Vassar, R
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2001, 17 (02) : 157 - 170
  • [9] β-secretase as a therapeutic target for Alzheimer's disease
    Ghosh, Arun K.
    Gemma, Sandra
    Tang, Jordan
    NEUROTHERAPEUTICS, 2008, 5 (03) : 399 - 408
  • [10] γ-Secretase Modulator in Alzheimer's Disease: Shifting the End
    Xia, Weiming
    Wong, Stephen T.
    Hanlon, Eugene
    Morin, Peter
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (04) : 685 - 696